Q3 2025 results: Net sales of $533 million (+6% at actual rates); diluted EPS $0.60 Core sales +6% CER (constant exchange rates) driven by QIAstat-Dx (+11% CER), QuantiFERON (+11% CER) and Sample ...
Lauber raised guidance, stating, "We now expect net sales to range from $635 million to $660 million, from the previous range of $630 million to $660 million. Adjusted EBITDA is now predicted to range ...
Acquisition of $15M stone distributor on track to close before December 15; the multi-location business will add revenue, EBITDA, and scale in a fast-growing category. The deal, first announced in ...
Steven Fife, President and CEO, stated the company is "pleased with our fourth quarter results, including continued growth and improving margins." He reported that revenues grew approximately 13% year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results